റഷ്യ ക്യാൻസറിനെതിരെ എംആർഎൻഎ വാക്സിൻ വികസിപ്പിച്ചു. അടുത്ത വർഷം വിപണിയിലെത്തുമെന്നും സൗജന്യമായി ലഭ്യമാകുമെന്നും റഷ്യൻ ആരോഗ്യ മന്ത്രാലയം അറിയിച്ചു. പ്രീ-ക്ലിനിക്കൽ പരീക്ഷണങ്ങളിൽ വാക്സിൻ ട്യൂമർ കോശങ്ങളുടെ വളർച്ച തടയുന്നതായി കണ്ടെത്തി.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
